This website uses cookies
Read our Privacy policy and Terms of use for more information.
CV
+4

Sep 12, 2026
•
10 min read
REACT imaged 16,808 adults aged 18 to 70. More than half had atherosclerotic plaque, and a low ten-year risk estimate did not establish that arteries were plaque-free. Whether finding plaque earlier changes outcomes is still being tested.

CV
+4

Aug 15, 2026
•
9 min read
Lp(a) is the most common inherited cardiovascular risk factor in medicine — and the first outcomes trial that could give us a drug for it has gone quiet.

CV
+2

Jun 9, 2026
•
10 min read
Lp(a) drives heart attacks, strokes, and aortic stenosis in one in five people. Statins don’t touch it. Diet doesn’t move it. After six decades of therapeutic silence, 2026 is the year the verdict finally arrives — and a single gene edit may make the problem history.

CV
+3

Apr 15, 2026
•
16 min read
Muscle damage. Memory loss. Cancer. Diabetes. Four fears, one physician, and what the evidence actually shows.

CV
+3

Apr 11, 2026
•
12 min read
The receptor story that explains 40 years of cardiovascular outcomes data — and why the pleiotropic hypothesis was never the whole story.

Michael Albert, MD. Board-certified obesity medicine physician. Chief Medical Officer, Vineyard.
Get the evidence in your inbox
Free, twice a week. Every number sourced to the trial. Unsubscribe anytime.
© 2026 Michael Albert MD LLC · Not medical advice. Dr. Albert is Chief Medical Officer of Vineyard.